Skip to main content
VCbacked
Log inGet Started

Tisento Therapeutics

Cambridge, United States

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

$81.0M raised
Jul 2023
Series A
Health CareMedicalTherapeutics

Top Investors

VenrockPolaris PartnersInvusSanofi VenturesCyclerion Therapeutics

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tisento Therapeutics

How much funding has Tisento Therapeutics raised?
Tisento Therapeutics has raised $81.0M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Who are Tisento Therapeutics's investors?
Tisento Therapeutics's investors include Venrock, Polaris Partners, Invus, Sanofi Ventures, Cyclerion Therapeutics.
Where is Tisento Therapeutics headquartered?
Tisento Therapeutics is headquartered in Cambridge, United States.
What does Tisento Therapeutics do?
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
What stage is Tisento Therapeutics at?
Tisento Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tisento Therapeutics — Funding & Investors." VCBacked, July 31, 2023, https://www.vcbacked.co/company/tisento-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Tisento Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tisento-therapeutics
Wikipedia (cite web)
{{cite web |title=Tisento Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tisento-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K